세계의 복합 약물 진단 시장 : 제품별, 용도별, 국가별, 지역별-산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

REPORT HIGHLIGHT

The combination medications and diagnostic tools plays a crucial role in modern healthcare, particularly in the realm of personalized medicine and targeted therapies. A combination product refers to a therapeutic or diagnostic product that combines drugs, medical devices, and/or biological products. Such products typically involve at least two of these categories and sometimes encompass all three. Common examples include traditional drug-device combinations, such as a syringe pre-filled with medication, as well as co-packaged or kitted products, like a first-aid kit containing bandages and pain-relieving medications. In the healthcare field, diagnostics pertain to the identification of the nature and cause of a disease or condition. Diagnostic tools encompass various techniques, including imaging, laboratory tests, and other medical assessments.

Combination Drugs Diagnostic Market- Market Dynamics

The market growth is anticipated to be driven by the increasing number of elderly individuals and advancements in diagnostic techniques.

Aging populations necessitate more comprehensive healthcare solutions, and one approach to address this is through combination drugs that incorporate diagnostic capabilities. These drugs offer a holistic approach to managing the health of elderly individuals. The World Health Organization predicts that by 2030, 1 in 6 people worldwide will be aged 60 years or over, resulting in an increase in the population aged 60 years and over from 1 billion in 2020 to 1.4 billion. The advancement of diagnostics allows for the early detection of diseases and conditions, enabling timely intervention and the initiation of combination drug therapies at the earliest stages of illnesses. However, the COVID-19 pandemic has also contributed to this rise, with the adoption of remote doctor's appointments, patient monitoring, and telehealth services. The increasing number of smartphone users, which has surpassed 3 billion today and is projected to exceed 4 billion by 2023, has further boosted the popularity of healthcare apps. Additionally, medical technology statistics indicate that 1 in 5 Americans currently utilize fitness trackers or smartwatches, a number expected to grow by 20% by 2025. These advancements in medical technology and drug development present opportunities for the creation of innovative combination drugs. However, establishing reimbursement policies for combination drugs that include diagnostic components can pose a challenge.

Combination Drugs Diagnostic Market- Key Insights

• As per the analysis shared by our research analyst, the global Combination Drugs Diagnostic market is estimated to grow annually at a CAGR of around 9.2% over the forecast period (2023-2030)

• The Combination Drugs Diagnostic sector is expected to experience substantial growth as a result of an increase in disposable income and greater awareness of combination drugs.

• Based on product type segmentation, Antimicrobial catheters were predicted to show maximum market share in the year 2022

• Based on Application segmentation, Infectious Diseases was the leading type in 2022

• On the basis of region, North America was the leading revenue generator in 2022

Combination Drugs Diagnostic Market- Segmentation Analysis:

The Global Combination Drugs Diagnostic Market is segmented on the basis of Product Type, Application, and Region.

The market is divided into three categories based on product type: Ultrasound, Antimicrobial catheters, Cardiovascular catheters, urological catheters, Oximetry catheters, Bone graft substitutes, Porfimer sodium & steroid and Eluting electrodes. The market is currently dominated by antimicrobial catheters. However, companies that provide comprehensive solutions, including diagnostics, combination drug therapies, and antimicrobial catheters, may be able to tackle the intricate issues of infection prevention in healthcare and seize potential opportunities.

The market is divided into two categories based on application: Infectious Diseases, Cardiovascular Diseases, Psychiatric Disorders, and Respiratory Disorders. The market is largely influenced by Infectious Diseases. The amalgamation of drugs and diagnostics is proving to be a crucial factor in the realm of infectious diseases. This comprehensive approach facilitates more accurate and focused treatment plans, taking into account the unique features of pathogens and individual patient reactions.

Combination Drugs Diagnostic Market- Geographical Insights

Geographically, the market for Combination Drugs Diagnostics is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further categorized based on the countries involved in business activities. The growth of the Combination Drugs Diagnostic market is expected to be dominated by North America, primarily due to the increasing investments in research and development (R&D) operations. North America, especially the United States, is recognized as a global center for pharmaceutical and biotechnology R&D. The substantial investments in R&D operations contribute to the development of innovative combination drugs that incorporate diagnostic components. According to the National Center for Science and Engineering Statistics (NCSES) within the National Science Foundation, the total expenditure on R&D activities in the United States reached USD 717.0 billion in 2020. Europe holds the second-largest market share, driven by the rising prevalence of chronic diseases such as cancer, heart disease, and diabetes.

Combination Drugs Diagnostic Market- Competitive Landscape:

The landscape of the market for combination drug diagnostics has been dynamic, with numerous companies contributing to the advancement and commercialization of diagnostic tools for guiding combination drug therapies. The manufacturers are actively involved in developing diagnostics that support combination drug therapies. A significant portion of the new generation of targeted therapies being introduced in clinical settings require patients to undergo essential tests that are necessary for the therapy's indication, known as companion diagnostics. Additionally, there are tests known as complementary diagnostics that support treatment decisions but are not essential prior to prescription. This shift in the way pharmaceutical companies develop new medicines has led to a significant increase in the number of drug-diagnostic combinations seeking regulatory approval. The growing trend towards personalized medicine, where treatment decisions are tailored to individual patient characteristics, is a major driving force in the combination drugs diagnostic market. Ongoing technological advancements, particularly in diagnostic technologies and imaging, play a crucial role in shaping the competitive landscape.

Recent Developments:

Roche's Columvi has been granted FDA approval as a third-line treatment for diffuse large B-cell lymphoma, a type of blood cancer. This new drug will now compete with AbbVie's Epkinly, which was recently approved for the same condition. The approval of Roche's new drug provides patients with another therapeutic option.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET KEY PLAYERS

• Abbott Laboratories
• Roche
• Novartis International AG
• GlaxoSmithKline plc.
• Pfizer Inc.
• Sanofi
• Bristol-Myers Squibb Company
• Johnson & Johnson
• Eli Lilly and Company
• Gilead Sciences, Inc.

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET, BY PRODUCT TYPE

• Ultrasound
• Antimicrobial catheters
• Cardiovascular catheters
• Urological catheters
• Oximetry catheters
• Bone graft substitutes
• Porfimer sodium & steroid
• Eluting electrodes

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET, BY APPLICATION

• Infectious Diseases
• Cardiovascular Diseases
• Psychiatric Disorders
• Respiratory Disorders

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET, BY REGION

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Combination Drugs Diagnostic Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Combination Drugs Diagnostic Market Snippet by Product Type
  • 2.1.2. Combination Drugs Diagnostic Market Snippet by Application
  • 2.1.3. Combination Drugs Diagnostic Market Snippet by Country
  • 2.1.4. Combination Drugs Diagnostic Market Snippet by Region
• 2.2. Competitive Insights

3. Combination Drugs Diagnostic Key Market Trends

• 3.1. Combination Drugs Diagnostic Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Combination Drugs Diagnostic Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Combination Drugs Diagnostic Market Opportunities
• 3.4. Combination Drugs Diagnostic Market Future Trends

4. Combination Drugs Diagnostic Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Combination Drugs Diagnostic Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Combination Drugs Diagnostic Market Landscape

• 6.1. Combination Drugs Diagnostic Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Combination Drugs Diagnostic Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
  • 7.1.2. Ultrasound
  • 7.1.3. Antimicrobial catheters
  • 7.1.4. Cardiovascular catheters
  • 7.1.5. Urological catheters
  • 7.1.6. Oximetry catheters
  • 7.1.7. Bone graft substitutes
  • 7.1.8. Porfimer sodium & steroid
  • 7.1.9. Eluting electrodes

8. Combination Drugs Diagnostic Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
  • 8.1.2. Infectious Diseases
  • 8.1.3. Cardiovascular Diseases
  • 8.1.4. Psychiatric Disorders
  • 8.1.5. Respiratory Disorders

9. Combination Drugs Diagnostic Market- By Geography

• 9.1. Introduction
  • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 9.2. North America
  • 9.2.1. Overview
  • 9.2.2. Combination Drugs Diagnostic Key Manufacturers in North America
  • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.2.6. U.S.
    • 9.2.6.1. Overview
    • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.2.7. Canada
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 9.3. Europe
  • 9.3.1. Overview
  • 9.3.2. Combination Drugs Diagnostic Key Manufacturers in Europe
  • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.6. Germany
    • 9.3.6.1. Overview
    • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.7. Italy
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.8. United Kingdom
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.9. France
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.10. Russia
    • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.11. Netherlands
    • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.12. Sweden
    • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.13. Poland
    • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.14. Rest of Europe
    • 9.3.14.1. Overview
    • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 9.4. Asia Pacific (APAC)
  • 9.4.1. Overview
  • 9.4.2. Combination Drugs Diagnostic Key Manufacturers in Asia Pacific
  • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.6. India
    • 9.4.6.1. Overview
    • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.7. China
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.8. Japan
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.9. South Korea
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.10. Australia
    • 9.4.10.1. Overview
    • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.11. Thailand
    • 9.4.11.1. Overview
    • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.12. Indonesia
    • 9.4.12.1. Overview
    • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.13. Philippines
    • 9.4.13.1. Overview
    • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.14. Rest of APAC
    • 9.4.14.1. Overview
    • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 9.5. Latin America
  • 9.5.1. Overview
  • 9.5.2. Combination Drugs Diagnostic Key Manufacturers in Latin America
  • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5.6. Brazil
    • 9.5.6.1. Overview
    • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5.7. Mexico
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5.8. Argentina
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5.9. Colombia
    • 9.5.9.1. Overview
    • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5.10. Rest of LATAM
    • 9.5.10.1. Overview
    • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 9.6. Middle East and Africa
  • 9.6.1. Overview
  • 9.6.2. Combination Drugs Diagnostic Key Manufacturers in Middle East and Africa
  • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.6. Saudi Arabia
    • 9.6.6.1. Overview
    • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.7. United Arab Emirates
    • 9.6.7.1. Overview
    • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.8. Israel
    • 9.6.8.1. Overview
    • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.9. Turkey
    • 9.6.9.1. Overview
    • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.10. Algeria
    • 9.6.10.1. Overview
    • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.11. Egypt
    • 9.6.11.1. Overview
    • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.12. Rest of MEA
    • 9.6.12.1. Overview
    • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Combination Drugs Diagnostic Industry

• 10.1. Competitive Dashboard
• 10.2. Company Profiles
  • 10.2.1. Abbott Laboratories
  • 10.2.2. Roche
  • 10.2.3. Novartis International AG
  • 10.2.4. GlaxoSmithKline plc.
  • 10.2.5. Pfizer Inc.
  • 10.2.6. Sanofi
  • 10.2.7. Bristol-Myers Squibb Company
  • 10.2.8. Johnson & Johnson
  • 10.2.9. Eli Lilly and Company
  • 10.2.10. Gilead Sciences, Inc.

11. 360 Degree Analyst View

12. Appendix

• 12.1. Research Methodology
• 12.2. References
• 12.3. Abbreviations
• 12.4. Disclaimer
• 12.5. Contact Us